|View printer-friendly version|
WILMINGTON, Mass.--(BW HealthWire)--March 21, 2001--Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it closed its public offering of 8,050,000 shares of common stock (which included the underwriters' over-allotment option to purchase an additional 1,050,000 shares) at $19 per share. Of the 8,050,000 shares, 3,500,000 were sold by the Company and 4,550,000 were sold by selling stockholders. The joint lead managers for the offering were Credit Suisse First Boston and Lehman Brothers.
|CONTACT:||Dennis R. Shaughnessy|
|978-658-6000 ext. 1329|